SG10201803541TA - Biologically active c-terminal arginine-containing peptides - Google Patents

Biologically active c-terminal arginine-containing peptides

Info

Publication number
SG10201803541TA
SG10201803541TA SG10201803541TA SG10201803541TA SG10201803541TA SG 10201803541T A SG10201803541T A SG 10201803541TA SG 10201803541T A SG10201803541T A SG 10201803541TA SG 10201803541T A SG10201803541T A SG 10201803541TA SG 10201803541T A SG10201803541T A SG 10201803541TA
Authority
SG
Singapore
Prior art keywords
containing peptides
biologically active
terminal arginine
arginine
terminal
Prior art date
Application number
SG10201803541TA
Inventor
James Wilkins
Masaru Shiratori
Tim Breece
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of SG10201803541TA publication Critical patent/SG10201803541TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Abstract

BIOLOGICALLYACTIVE C-TERMINAL ARGININE-CONTAINING PEPTIDES The present invention concerns the separation, identification and characterization of active peptide fragments from peptones. Figure: 23
SG10201803541TA 2007-09-05 2008-09-05 Biologically active c-terminal arginine-containing peptides SG10201803541TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96764407P 2007-09-05 2007-09-05

Publications (1)

Publication Number Publication Date
SG10201803541TA true SG10201803541TA (en) 2018-06-28

Family

ID=40084302

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2013032669A SG190602A1 (en) 2007-09-05 2008-09-05 Biologically active c-terminal arginine-containing peptides
SG10201803541TA SG10201803541TA (en) 2007-09-05 2008-09-05 Biologically active c-terminal arginine-containing peptides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2013032669A SG190602A1 (en) 2007-09-05 2008-09-05 Biologically active c-terminal arginine-containing peptides

Country Status (15)

Country Link
US (5) US20090143248A1 (en)
EP (1) EP2207790B1 (en)
JP (1) JP5734653B2 (en)
CN (2) CN101848925A (en)
CA (1) CA2697519C (en)
CY (1) CY1114618T1 (en)
DK (1) DK2207790T3 (en)
ES (1) ES2434829T3 (en)
HK (1) HK1213916A1 (en)
HR (1) HRP20131108T1 (en)
PL (1) PL2207790T3 (en)
PT (1) PT2207790E (en)
SG (2) SG190602A1 (en)
SI (1) SI2207790T1 (en)
WO (1) WO2009033024A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2207790B1 (en) * 2007-09-05 2013-08-21 Genentech, Inc. Biologically active c-terminal arginine-containing peptides
DE102010001983A1 (en) * 2010-02-16 2011-08-18 peptides&elephants GmbH, 14558 A process for producing a graphite-based peptide purification material and process for peptide purification
WO2012030217A2 (en) 2010-08-31 2012-03-08 Friesland Brands B.V. Culture medium for eukaryotic cells
ES2758451T3 (en) * 2012-09-19 2020-05-05 Gemvax & Kael Co Ltd Cell penetration peptide, conjugate comprising the same and composition comprising the conjugate
WO2017178193A1 (en) * 2016-04-14 2017-10-19 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for the identification of random polynucleotide or polypeptide sequences with biological activity
CN109575106A (en) * 2019-01-07 2019-04-05 无限极（中国）有限公司 A kind of method and application preparing anti-oxidant tripeptides from big mpd polypeptide
US20240101599A1 (en) * 2020-12-22 2024-03-28 Maruhachi Muramatsu, Inc. Peptide, cell growth promoter, protein production promoter, culture medium, cell growth method using peptide, and protein production method using peptide
CN116444610A (en) * 2022-11-30 2023-07-18 内蒙古伊利实业集团股份有限公司 Milk active peptide DASAQUR and preparation method and application thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
KR900007085B1 (en) * 1985-10-22 1990-09-28 플랜트 제네틱스, 인코포레이티드 Methods for enhanced somatic enbryogenesis
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
EP0435911B1 (en) 1988-09-23 1996-03-13 Cetus Oncology Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
EP0810283A3 (en) 1996-05-31 1997-12-10 Akzo Nobel N.V. Live attenuated RTX-procucing bacteria of the family Pasteurellaceae
US6770275B1 (en) * 1996-05-31 2004-08-03 Akzo Nobel N.V. Live attenuated RTC-producing bacteria of the family
US20020045266A1 (en) * 2000-02-08 2002-04-18 Hicham Fenniri Method for determining the structure of an active member of a chemical library
US7041506B2 (en) * 2001-11-19 2006-05-09 Becton Dickinson And Company Peptides promoting cell adherence, growth and secretion
WO2004035608A2 (en) * 2002-10-18 2004-04-29 Abgenix, Inc. System and method for cleaving antibodies
EP2207790B1 (en) * 2007-09-05 2013-08-21 Genentech, Inc. Biologically active c-terminal arginine-containing peptides
EP2490021A1 (en) * 2011-02-18 2012-08-22 Biotempt B.V. Modulators of PRR and GPCR signalling

Also Published As

Publication number Publication date
PL2207790T3 (en) 2014-01-31
DK2207790T3 (en) 2013-10-28
US20110183413A1 (en) 2011-07-28
EP2207790A1 (en) 2010-07-21
CA2697519A1 (en) 2009-03-12
US20210163880A1 (en) 2021-06-03
JP2010538089A (en) 2010-12-09
HK1213916A1 (en) 2016-07-15
PT2207790E (en) 2013-11-04
ES2434829T3 (en) 2013-12-17
SG190602A1 (en) 2013-06-28
CY1114618T1 (en) 2016-10-05
CN104844690A (en) 2015-08-19
HRP20131108T1 (en) 2014-01-31
CA2697519C (en) 2018-11-20
WO2009033024A1 (en) 2009-03-12
US20170088813A1 (en) 2017-03-30
JP5734653B2 (en) 2015-06-17
SI2207790T1 (en) 2013-11-29
US20090143248A1 (en) 2009-06-04
EP2207790B1 (en) 2013-08-21
US20170321187A1 (en) 2017-11-09
CN101848925A (en) 2010-09-29
CN104844690B (en) 2019-08-16

Similar Documents

Publication Publication Date Title
SG10201803541TA (en) Biologically active c-terminal arginine-containing peptides
NZ600732A (en) Oxyntomodulin peptide analogue
NZ624533A (en) Novel immunotherapy against several tumors including neuronal and brain tumors
NZ600731A (en) Oxyntomodulin peptide analogue
IN2014CN02050A (en)
WO2006090810A3 (en) Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
EA201170878A1 (en) POLYPEPTIDES WITH XYLANASE ACTIVITY
MX2009004147A (en) Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides.
IL232501A (en) Proteinase-resistant analogs of peptide or polypeptide and uses thereof
RS53872B1 (en) Novel and powerful mhc-class ii peptides derived from survivin and neurocan
NZ602119A (en) Peptide vaccines for cancers expressing tumor-associated antigens
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
MY148447A (en) Method for amidating polypeptides with basic aminoacid d-terminals by means of specific endoproteases
WO2005074626A3 (en) Compositions, methods and uses for a novel family of peptides
WO2008093058A3 (en) Peptides and their use
WO2011036443A3 (en) Si protease c- terminal polypeptides and uses thereof for treating inflammation or coagulation disorders
WO2010144231A3 (en) Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
WO2006046239A3 (en) A thymus-specific protein
WO2007101146A3 (en) Selective vpac2 receptor peptide agonists
WO2008113536A8 (en) Neurotrophic peptides
NZ601647A (en) Variant hhip1 protein and methods and uses thereof
NZ589365A (en) Peptidyl diacylglycerides
WO2011073918A3 (en) Peptides as modulators of fprl1 and/or fprl2
NZ592461A (en) Rab6kifl/kif20a epitope peptide and vaccines containing the same
WO2010103515A3 (en) Compositions and methods for prevention and treatment of neurodegenerative diseases